Campbell & CO Investment Adviser LLC Abbott Laboratories Transaction History

Campbell & CO Investment Adviser LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.32 Million - $1.48 Million	13,122 Added 184.76%	20,224 $2.1 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $777,811 - $859,057	7,102 New	7,102 $807,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $1.29 Million - $1.51 Million	13,269 New	13,269 $1.34 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $828,286 - $916,326	-7,100 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $751,109 - $884,163	7,100 New	7,100 $823,000
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $799,635 - $1.17 Million	-12,729 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $673,066 - $749,280	8,573 Added 206.28%	12,729 $1.11 Million
Q3 2019 Oct 16, 2019	BUY	$81.84 - $88.74 $340,127 - $368,803	4,156 New	4,156 $348,000
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $338,407 - $408,248	-5,565 Closed	0 $0
Q2 2018 Jul 13, 2018	BUY	$57.57 - $63.54 $320,377 - $353,600	5,565 New	5,565 $339,000

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.